Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis

Arnett, 1988, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum, 31, 315, 10.1002/art.1780310302 Visser, 2002, How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis, Arthritis Rheum, 46, 357, 10.1002/art.10117 Vossenaar, 2003, PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease, Bioessays, 25, 1106, 10.1002/bies.10357 Zendman, 2004, Autoantibodies to citrullinated (poly)peptides: a key diagnostic and prognostic marker for rheumatoid arthritis, Autoimmunity, 37, 295, 10.1080/08916930410001708733 Pruijn, 2005, Anti-CCP antibody detection facilitates early diagnosis and prognosis of rheumatoid arthritis, Curr Rheum Rev, 1, 1, 10.2174/1573397052954208 van Gaalen, 2005, A comparison of the diagnostic accuracy and prognostic value of the first-and second anti-cyclic citrullinated peptides autoantibody (CCP1 and CCP2) tests for rheumatoid arthritis, Ann Rheum Dis, 64, 1510, 10.1136/ard.2004.035089 Riedemann, 2005, The use of second generation anti-CCP antibody (anti-CCP2) testing in rheumatoid arthritis — a systematic review, Clin Exp Rheumatol, 23, S69 Zendman, 2006, Use and significance of anti-CCP autoantibodies in rheumatoid arthritis, Rheumatology, 45, 20, 10.1093/rheumatology/kei111 Kroot, 2000, The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis, Arthritis Rheum, 43, 1831, 10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6 Vallbracht, 2004, Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis, Ann Rheum Dis, 63, 1079, 10.1136/ard.2003.019877 Wener, 2004, Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia, Arthritis Rheum, 50, 2305, 10.1002/art.20355 Bombardieri, 2004, Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement, Arthritis Res Ther, 6, R137, 10.1186/ar1041 Lopez-Hoyos, 2004, Clinical utility of anti-CCP antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica, Rheumatology (Oxford), 43, 655, 10.1093/rheumatology/keh143 Salvador, 2003, Prevalence and clinical significance of anti-cyclic citrullinated peptide and antikeratin antibodies in palindromic rheumatism. An abortive form of rheumatoid arthritis?, Rheumatology (Oxford), 42, 972, 10.1093/rheumatology/keg268 Gottenberg, 2004, Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjogren's syndrome, Ann Rheum Dis, 64, 114, 10.1136/ard.2003.019794 Vander Cruyssen, 2005, Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis, Ann Rheum Dis, 64, 1145, 10.1136/ard.2004.032177 Alenius, 2006, Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without manifestation of joint inflammation, Ann. Rheum. Dis., 65, 398, 10.1136/ard.2005.040998 Gao, 2005, Determination of anti-CCP antibodies in patients with suspected rheumatoid arthritis: does it help to predict the diagnosis before referral to a rheumatologist?, Ann Rheum Dis, 64, 1516, 10.1136/ard.2005.035444 Berglin, 2004, A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis, Arthritis Res Ther, 6, R303, 10.1186/ar1187 Rantapää-Dahlqvist, 2003, Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis, Arthritis Rheum, 48, 2741, 10.1002/art.11223 Nielen, 2004, Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors, Arthritis Rheum, 50, 380, 10.1002/art.20018 van Gaalen, 2004, Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study, Arthritis Rheum, 50, 709, 10.1002/art.20044 Vittecoq, 2004, Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non-citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis, Clin Exp Immunol, 135, 173, 10.1111/j.1365-2249.2004.02341.x Soderlin, 2004, Antibodies against cyclic citrullinated peptide (CCP) and levels of cartilage oligomeric matrix protein (COMP) in very early arthritis: relation to diagnosis and disease activity, Scand J Rheumatol, 33, 185, 10.1080/03009740310004856 Forslind, 2004, Prediction of radiological outcome in early RA in clinical practice: role of antibodies to citrullinated peptides (anti-CCP), Ann Rheum Dis, 63, 1090, 10.1136/ard.2003.014233 Kastbom, 2004, Anti-CCP antibody test predicts the disease course during three years in early rheumatoid arthritis (the TIRA project), Ann Rheum Dis, 63, 1085, 10.1136/ard.2003.016808 Rönnelid, 2005, Longitudinal analysis of anti-citrullinated protein/peptide antibodies (anti-CP) during 5 year follow-up in early rheumatoid arthritis: anti-CP status is a stable phenotype that predicts worse disease activity and greater radiological progression, Ann Rheum Dis, 64, 1744, 10.1136/ard.2004.033571 Maddali-Bongi, 2004, Anti-cyclic citrullinated peptide antibodies are highly associated with severe bone lesions in rheumatoid arthritis anti-CCP and bone damage in RA, Autoimmunity, 37, 495, 10.1080/08916930400011965 Berglin, 2006, Radiological outcome in rheumatoid arthritis is predicted by the presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-rheumatoid factor at disease onset, Ann. Rheum. Dis., 65, 453, 10.1136/ard.2005.041376 van Gaalen, 2004, Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis, Arthritis Rheum, 50, 2113, 10.1002/art.20316 de Rycke, 2004, Rheumatoid factor and anti-citrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations, Ann Rheum Dis, 63, 1587, 10.1136/ard.2003.017574 Lindqvist, 2005, Prognostic laboratory markers of joint damage in rheumatoid arthritis, Ann Rheum Dis, 64, 196, 10.1136/ard.2003.019992 Senkpiehl, 2005, HLA-DRB1 and anti-cyclic citrullinated peptide antibody production in rheumatoid arthritis, Int Arch Allergy Immunol, 137, 315, 10.1159/000086463 Verpoort, 2005, Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis, Arthritis Rheum, 52, 3058, 10.1002/art.21302 Smolen, 2003, Therapeutic strategies for rheumatoid arthritis, Nat Rev Drug Discov, 2, 473, 10.1038/nrd1109 O'Dell, 2002, Treating rheumatoid arthritis early: a window of opportunity?, Arthritis Rheum, 46, 283, 10.1002/art.10092 Robinson, 2002, Autoantigen microarrays for multiplex characterization of autoantibody responses, Nat Med, 8, 295, 10.1038/nm0302-295 Tampoia, 2005, Proteomic: new advances in the diagnosis of rheumatoid arthritis, Clin Chim Acta, 357, 219, 10.1016/j.cccn.2005.03.030